|
|
||||||||
The Journal of Neurophysiology Vol. 86 No. 6 December 2001, pp. 3061-3064
Copyright ©2001 by the American Physiological Society
RAPID COMMUNICATION
School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
Kelly, Sara and
Victoria Chapman.
Selective Cannabinoid CB1 Receptor Activation
Inhibits Spinal Nociceptive Transmission In Vivo.
J. Neurophysiol. 86: 3061-3064, 2001.
Cannabinoid1 (CB1)
receptors are located at CNS sites, including the spinal cord, involved
in somatosensory processing. Analgesia is one of the tetrad of
behaviors associated with cannabinoid agonists. Here, effects of a
potent cannabinoid CB1 receptor agonist arachidonyl-2-chloroethylamide (ACEA) on evoked responses of dorsal horn neurons in anesthetized rats were investigated. Extracellular recordings of convergent dorsal horn neurons were made in halothane anesthetized Sprague-Dawley rats (n = 16). Effects of
spinal application of ACEA on electrically evoked responses of dorsal
horn neurons were studied. Mean maximal effects of 0.5, 5, 50, and 500 ng/50 µl ACEA on the C-fiber-mediated postdischarge response were
79 ± 6, 62 ± 10, and 54 ± 7% (P < 0.01), 45 ± 6% (P < 0.01), of control, respectively.
ACEA (500 ng/50 µl) also reduced the C-fiber-evoked nonpotentiated
responses of neurons (59 ± 9% of control, P < 0.05) and A
-fiber-evoked responses of neurons (68 ± 10% of
control, P < 0.01). Minor effects of ACEA on
A
-fiber-evoked responses were observed. Spinal pre-administration of
the selective CB1 receptor antagonist SR141716A
(0.01 µg/50 µl) significantly reduced effects of ACEA (500 ng/50
µl) on postdischarge responses of dorsal horn neurons. This study
demonstrates that spinal CB1 receptors modulate
the transmission of C- and A
-fiber-evoked responses in anesthetized
rats; this may reflect pre- and/or postsynaptic effects of cannabinoids
on nociceptive transmission. CB1 receptors inhibit synaptic release of glutamate in rat dorsolateral striatum, a
similar mechanism of action may underlie the effects of ACEA on noxious
evoked responses of spinal neurons reported here.
| |
INTRODUCTION |
|---|
|
|
|---|
Cannabinoids
act at cannabinoid CB1/CB2
receptors coupled to Gi proteins, which inhibit adenylate cyclase and
modulate ion channel conductance (see Pertwee et al.
2001
). Synthetic cannabinoids and endocannabinoids, such as
anandamide, play an important role in the modulation of nociceptive
processing (see Pertwee et al. 2001
).
Electrophysiological studies have demonstrated that systemic (Hohmann et al. 1999
) and spinal (Drew et al.
2000
) administration of cannabinoids inhibits noxious evoked
responses of spinal neurons.
Cannabinoid receptors are located on presynaptic primary afferent
fibers and postsynaptic dorsal horn neurons of the spinal cord. Rat
dorsal root ganglion (DRG) neurons, predominantly medium- and
large-sized neurons, can make cannabinoid receptors and insert them on
primary afferent terminals (Hohmann and Herkenham 1999
). Recently, we have demonstrated functional CB1
receptors on adult DRG neurons in culture (Millns et al.
2001
). Cannabinoid CB1 receptors are also
located on spinal interneurons (Farquhar-Smith et al. 2000
).
To date, studies of the effects of cannabinoid agonists have used
nonselective agonists, such as HU210 (Drew et al. 2000
) and WIN 55,212-2 (Hohmann et al. 1999
), which act at
CB1 and CB2 receptors.
These anti-nociceptive effects of cannabinoids are partly blocked by
the selective CB1 receptor antagonist SR141716A (see Pertwee et al. 2001
), suggesting central
antinociceptive effects of the cannabinoids are mediated by
CB1 receptors.
Recently, a synthetic cannabinoid agonist
arachidonyl-2-chloroethylamide (ACEA) with a reported 2000-fold
selectivity for the CB1 receptor compared with
CB2 receptor has been described; ACEA has in vivo
activity in mice, producing hypothermia, one of the tetrad of behaviors
associated with cannabinoids (Hillard et al. 1999
). The
effect of this selective CB1 receptor agonist on
nociceptive transmission is unknown. Here, changes in noxious evoked
responses of spinal dorsal horn neurons following spinal administration
of ACEA in the rat are reported.
| |
METHODS |
|---|
|
|
|---|
The techniques used have been described previously (Drew
et al. 2000
). Extracellular recordings of convergent dorsal
horn neurons (mean depth, 784 ± 57 µm) were made with
parylene-coated tungsten electrodes (A-M Systems) in anesthetized
(1-1.5% halothane in 66% N2O-33%
O2) Sprague-Dawley rats (200-250 g,
n = 16). Neuronal responses to transcutaneous
electrical stimulation (3 times C-fiber threshold, trains of 16 stimuli
at 0.5 Hz delivered by fine stimulating electrodes made in house) of
the peripheral receptive field were recorded, and poststimulus
histograms were constructed. Evoked responses were separated and
quantified on the basis of latencies: A
-fiber: 0-20 ms
poststimulus; A
-fiber: 20-90 ms; C-fiber: 90-300 ms poststimulus.
The remaining late neuronal response (300-800 ms poststimulus),
occurring as neurons exhibit hyperexcitability following repetitive
stimulation, was taken as the C-fiber-mediated postdischarge response
of the neuron. The baseline C-fiber-evoked neuronal responses were
calculated as the number of action potentials produced by the first
stimulation multiplied by the total number of stimuli (16), this
response was termed the nonpotentiated response.
Effects of spinal administration of ACEA (0.5-500 ng/50 µl) on evoked responses of dorsal horn neurons (n = 9) in anesthetized rats (n = 9) were studied. Drug effects were measured at 10-min intervals for 50-min postdrug administration. The ability of preadministration (1 h) of the selective CB1 receptor antagonist SR141716A (0.01 µg/50 µl) to block the effect of ACEA (500 ng/50 µl) was studied in separate groups of rats (n = 7). SR141716A was dissolved in distilled H2O and ethanol (<0.1% ethanol), at this concentration SR141716A alone had no effect (data not shown).
Mean maximal effects of ACEA are presented as percentage of the control response ± SE; statistical analysis was performed with repeated-measures ANOVA and Dunnett's multiple comparison test. Comparison of the effect of ACEA in the presence and absence of SR141716A on evoked responses were made with area under the curve (AUC) analysis (percentage control response vs. time postdrug administration). Statistical analysis of AUCs was performed with the Mann-Whitney test.
| |
RESULTS |
|---|
|
|
|---|
Dorsal horn neurons with peripheral receptive fields on the hindpaw were used in this study. C-fiber thresholds of activation, response latency of C-fiber responses and control A- and C-fiber-evoked responses of dorsal horn neurons were measured (Table 1). An example of a control response of a single neuron and a poststimulus histogram after transcutaneous stimulation are depicted in Fig. 1A.
|
|
Spinal administration of ACEA (0.5-500 ng/50 µl) inhibited
C-fiber-mediated postdischarge responses of dorsal horn neurons in a
dose-related manner (Fig. 1, A-E). Mean maximal effects of 0.5, 5, 50, and 500 ng/50 µl ACEA on the postdischarge responses of
neurons were 79 ± 6, 62 ± 10, 54 ± 7%
(P < 0.01), 45 ± 6% (P < 0.01), of control, respectively. Spinal ACEA (500 ng/50 µl) also
reduced the C-fiber-evoked nonpotentiated responses of neurons (59 ± 9% of control, P < 0.05) and A
-fiber-evoked
responses of neurons (68 ± 10% of control, P < 0.01). By contrast, spinal ACEA had minor effects on A
-fiber-evoked
responses of dorsal horn neurons (data not shown).
Spinal administration of the selective CB1
receptor antagonist SR141716A (0.01 µg/50 µl) significantly blocked
the inhibitory effect of ACEA (500 ng/50 µl) on the C-fiber-mediated
postdischarge response of neurons (ACEA: AUC = 2,677 ± 384, ACEA/SR141716A: AUC = 4,626 ± 449, P < 0.05, Fig. 2). Effects of ACEA on the
nonpotentiated component of the C-fiber-evoked response and
A
-fiber-evoked responses were also reduced by spinal administration
of SR141716A (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
This study demonstrates that activation of spinal
CB1 receptors reduces nociceptive transmission.
ACEA selectively inhibited A
- and C-fiber-mediated responses of
dorsal horn neurons in anesthetized rats; A
-fiber-evoked responses
were unaffected. These results corroborate our recent report that the
nonselective cannabinoid agonist HU210 inhibits noxious evoked
responses of dorsal horn neurons and that HU210 stimulates
[35S]GTP
S binding in
spinal cord slices of rats (Drew et al. 2000
). The
selective CB1 antagonist SR141716A blocked the
inhibitory effect of ACEA reported here.
The synaptic sites and cellular mechanisms by which cannabinoids
selectively inhibit nociceptive transmission at the level of the spinal
cord remains unresolved. Indeed these effects could be mediated by both
pre- and/or postsynaptic cannabinoid receptors (see earlier).
Cannabinoid receptor-mediated inhibitions of N- and P/Q-type calcium
channels have been reported in cultured rat hippocampal neurons
(Twitchell et al. 1997
). Given the role of N- and P-type
calcium channels in nociceptive transmission (Diaz and Dickenson
1997
), it is feasible that cannabinoid receptor-mediated inhibition of these channels contributes to the effects of cannabinoid agonists on C-fiber-driven neuronal responses. Evidence suggests that
activation of CB1 receptors inhibits synaptic
release of glutamate in rat dorsalateral striatum (Gerdeman and
Lovinger 2001
); a similar mechanism of action may underlie the
observed effects of ACEA on noxious evoked responses of dorsal horn
neurons reported here.
| |
ACKNOWLEDGMENTS |
|---|
ACEA was a gift from Dr. C. Hillard and SR141716A was provided by Research Biochemicals International as part of the chemical synthesis program of the National Institute of Mental Health, Contract N01MH-30003.
The Wellcome Trust and the University of Nottingham (S. Kelly) supported this study.
| |
FOOTNOTES |
|---|
Address for reprint requests: V. Chapman, School of Biomedical Sciences, E Floor, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK (E-mail: victoria.chapman{at}nottingham.ac.uk).
Received 5 March 2001; accepted in final form 14 August 2001.
| |
REFERENCES |
|---|
|
|
|---|
S binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
Eur J Neurosci
12:
2079-2086, 2000[ISI][Medline].This article has been cited by other articles:
![]() |
S. Akerman, P. R. Holland, and P. J. Goadsby Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 64 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Johanek and D. A. Simone Cannabinoid Agonist, CP 55,940, Prevents Capsaicin-Induced Sensitization of Spinal Cord Dorsal Horn Neurons J Neurophysiol, February 1, 2005; 93(2): 989 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Nackley, A. M. Zvonok, A. Makriyannis, and A. G. Hohmann Activation of Cannabinoid CB2 Receptors Suppresses C-Fiber Responses and Windup in Spinal Wide Dynamic Range Neurons in the Absence and Presence of Inflammation J Neurophysiol, December 1, 2004; 92(6): 3562 - 3574. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. J. Wallace, D. F. Cottrell, P. J. Brophy, and S. M. Fleetwood-Walker Focal Lysolecithin-Induced Demyelination of Peripheral Afferents Results in Neuropathic Pain Behavior That Is Attenuated by Cannabinoids J. Neurosci., April 15, 2003; 23(8): 3221 - 3233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rawls, A. Cowan, R. J. Tallarida, E. B. Geller, and M. W. Adler N-Methyl-D-aspartate Antagonists and WIN 55212-2 [4,5-Dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a Cannabinoid Agonist, Interact to Produce Synergistic Hypothermia J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |